In our data, the RNA and protein levels of TGFB1I1 were significantly increased along with increasing astrocytoma grades and high expression of TGFB1I1 indicates a poor survival in patients with astrocytomas. Here, TGFB1I1 is linked to astrocytoma (excluding glioblastoma).